The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19
- 8 May 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Pharmacotherapy
- Vol. 6 (4), 262-264
- https://doi.org/10.1093/ehjcvp/pvaa048
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Chest CT Features of COVID-19 in Rome, ItalyRadiology, 2020
- IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitisLife Science Alliance, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Warfarin–Antiretroviral InteractionsAnnals of Pharmacotherapy, 2009